Literature DB >> 1326897

Fibrosarcoma-malignant fibrous histiocytoma of the breast. A clinicopathological study of 32 cases.

M W Jones1, H J Norris, E S Wargotz, S W Weiss.   

Abstract

We report the clinical and pathologic features of 32 sarcomas of the breast with features spanning the spectrum of fibrosarcomas-malignant fibrous histiocytomas. Neoplasms were categorized as high- or low-grade lesions depending on a combination of the degrees of atypia and mitotic activity. The majority of high-grade lesions had marked (3+) nuclear atypia and at least five mitotic figures per 10 hpf. High-grade lesions with moderate (2+) nuclear atypia had a mitotic activity of six or more mitotic figures per 10 hpf. All low-grade lesions had five or fewer mitotic figures per 10 hpf, and none had a score of the nuclear grade times mitotic figures of more than 10. The average mitotic activity in low-grade lesions was two mitotic figures per 10 hpf; the high-grade lesions had 12 mitotic figures per 10 hpf. Sixty-nine percent of the low-grade fibrosarcomas-malignant fibrous histiocytomas showed mild (1+) cytologic atypia, and 69% of the high-grade lesions showed severe (3+) cytologic atypia. The herringbone pattern was associated with a more favorable prognosis than the malignant fibrous histiocytoma pattern. Compared to the high-grade lesions, low-grade fibrosarcomas-malignant fibrous histiocytomas were slow-growing, produced fewer recurrences, and did not metastasize. Of the 16 women with low-grade lesions, all were free of tumor at last contact, despite recurrence in more than half of the patients. In contrast, 31% of the patients with high-grade lesions died of tumor, and 13% were alive with disease. Twenty-five percent of women with high-grade lesions developed distant metastases.

Entities:  

Mesh:

Year:  1992        PMID: 1326897     DOI: 10.1097/00000478-199207000-00005

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  5 in total

1.  Giant cell tumor of the breast.

Authors:  Masaharu Fukunaga
Journal:  Virchows Arch       Date:  2002-04-19       Impact factor: 4.064

2.  Primary well differentiated breast liposarcoma with divergent cartilagenous differentiation: a case report.

Authors:  Ammar Cherkess Al-Rikabi; Mohamed Sharif El-Sharkawy; Abdulaziz Al-Seif
Journal:  Oman Med J       Date:  2013-03

3.  Giant cell malignant fibrous histiocytoma of the breast: a case report.

Authors:  Se Jeong Oh; Kyoung Mee Kim; Tae Ho Hong; Woo Chan Park; Jeong Soo Kim; Sang Seol Jung
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

Review 4.  Primary soft tissue sarcoma of the breast.

Authors:  J C Trent II; R S Benjamin; V Valero
Journal:  Curr Treat Options Oncol       Date:  2001-04

Review 5.  Diagnostic and therapeutic strategy and the most efficient prognostic factors of breast malignant fibrous histiocytoma.

Authors:  Si-Qi Qiu; Xiao-Long Wei; Wen-He Huang; Ming-Yao Wu; Yun-Sheng Qin; Yang-Kang Li; Guo-Jun Zhang
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.